Naïs Prade
Centre National de la Recherche Scientifique(FR)Université Toulouse III - Paul Sabatier(FR)Inserm(FR)Université Fédérale de Toulouse Midi-Pyrénées(FR)Centre Hospitalier Universitaire de Toulouse(FR)Centre de Recherche en Cancérologie de Toulouse(FR)La Ligue Contre le Cancer(FR)Institut universitaire du cancer de Toulouse Oncopole(FR)Toulouse Mathematics Institute(FR)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, CAR-T cell therapy research, Acute Myeloid Leukemia Research
Most-Cited Works
- → Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.(2019)121 cited
- → Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogénétique Hématologique study(2010)109 cited
- → del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma(2020)81 cited
- → Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia(2017)54 cited
- → Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia(2020)51 cited
- → The gene expression profile of phosphoantigen‐specific human γδ T lymphocytes is a blend of αβ T‐cell and NK‐cell signatures(2011)50 cited